AUTONOMIX MEDICAL INC (AMIX) Stock Price, Forecast & Analysis
NASDAQ:AMIX • US05330T2050
AMIX Key Statistics, Chart & Performance
The current stock price of AMIX is 0.3833 USD. In the past month the price decreased by -26.33%. In the past year, price decreased by -86.5%.
AMIX Technical Analysis
AMIX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AMIX. While AMIX has a great health rating, there are worries on its profitability.
AMIX Financial Highlights
Over the last trailing twelve months AMIX reported a non-GAAP Earnings per Share(EPS) of -5.72. The EPS increased by 63.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -210.43% | ||
| ROE | -258.98% | ||
| Debt/Equity | 0 |
AMIX Forecast & Estimates
8 analysts have analysed AMIX and the average price target is 6.73 USD. This implies a price increase of 1656.33% is expected in the next year compared to the current price of 0.3833.
AMIX Ownership
AMIX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.62 | 193.832B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.53 | 169.664B | ||
| SYK | STRYKER CORP | 24.21 | 139.908B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.34 | 109.921B | ||
| BDX | BECTON DICKINSON AND CO | 11.16 | 50.66B | ||
| IDXX | IDEXX LABORATORIES INC | 42.48 | 49.283B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.52 | 44.358B | ||
| RMD | RESMED INC | 20.57 | 35.869B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16 | 35.845B | ||
| DXCM | DEXCOM INC | 27.73 | 25.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AMIX
Company Profile
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
Company Info
AUTONOMIX MEDICAL INC
21 Waterway Ave, Suite 300
The Woodlands TEXAS US
Employees: 10
Phone: 18322777816
AUTONOMIX MEDICAL INC / AMIX FAQ
Can you describe the business of AUTONOMIX MEDICAL INC?
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
What is the current price of AMIX stock?
The current stock price of AMIX is 0.3833 USD. The price increased by 0.87% in the last trading session.
Does AUTONOMIX MEDICAL INC pay dividends?
AMIX does not pay a dividend.
What is the ChartMill technical and fundamental rating of AMIX stock?
AMIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in AUTONOMIX MEDICAL INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AMIX.
What is AUTONOMIX MEDICAL INC worth?
AUTONOMIX MEDICAL INC (AMIX) has a market capitalization of 2.65M USD. This makes AMIX a Nano Cap stock.